Redx Pharma plc Holding(s) in Company (3730P)
November 16 2016 - 10:22AM
UK Regulatory
TIDMREDX
RNS Number : 3730P
Redx Pharma plc
16 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
----------------------------------------------------------------------------------------------------
1. Identity of the issuer or Redx Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------------- -----------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------- -------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------- -------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------- -------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------- -------------------------------
Other (please
specify):
--------------------------------------------------------- -------- -------------------------------
3. Full name of person(s) Alderley Park Holdings Limited
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- ---------------------------------------
5. Date of the transaction 21(st) September 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------------------
6. Date on which issuer 15(th) November 2016
notified:
----------------------------------------------------------- ---------------------------------------
7. Threshold(s) that is/are 4% to 3% Change at Direct
crossed or Interest Level
reached: (vi, vii)
----------------------------------------------------------- ---------------------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ----------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- ------------- -------------------------- ---------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- ------------- ------------- ----------- ------------ -------------
Ordinary
shares of
GBP0.01
each 3,855,084 3,855,084 3,605,084 3,605,084 3.9%
--------------- --------------- ------------- --------------- --------- ------------ -------------
GB00BSNB6S51
------------- ----------- ----------- ----------- ----------- --------- -------- -----------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------ ---------------------------- -----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- --------------- ---------------------------- -------------------------
Nominal Delta
--------------- ------------- ------------- --------------- ---------------------------- ------------ -----------
Total (A+B+C)
-----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- --------------------------------------------------------------------
3,605,084 3.9%
------------------------------------------------- --------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- --------------
13. Additional information:
------------------------------------------------------------- --------------
14. Contact name: Andy Allan
------------------------------------------------------------- --------------
15. Contact telephone number: 0161 232 4573
------------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBUBDBGDBBGLL
(END) Dow Jones Newswires
November 16, 2016 10:22 ET (15:22 GMT)
Redx Pharma (LSE:REDX)
Historical Stock Chart
From Apr 2024 to May 2024
Redx Pharma (LSE:REDX)
Historical Stock Chart
From May 2023 to May 2024